February 2013 Highlights

Om avsnittet

This audio program contains research that considers clozapine as a first-line treatment for schizophrenia, a recently developed scale for negative symptoms, the new DSM-5 diagnosis disruptive mood dysregulation disorder, the effects of mental health parity in the Federal Employees Health Benefits Program, and a surprising finding on successful aging. Articles can be viewed online at www.ajp.psychiatryonline.org.

Om avsnittet

Fler avsnitt

October 2026: The RECOVER Trial of Vagus Nerve Stimulation in Markedly Treatment-Resistant Depression: Critical Findings, Lessons Learned, and Future Directions

September 2026: Circadian Rhythm Stabilization App to Prevent Mood Episode Recurrence in Patients With Mood Disorders: A Multicenter, Double-Blind, Sham-Controlled, Randomized Clinical Trial

81: Psychiatric Risk Associated With Large Language Model Chatbots: An Emerging Concern

August 2026: Cognitive, Electrophysiological, and Behavioral Presentation of First-Episode Psychosis With or Without Cannabis Exposure

July 2026: Social Determinants of Health in Psychiatric Disorders: Exciting Opportunities for Biopsychosocial Research and Clinical Care

June 2026: Low-Dose Buprenorphine Following Ketamine Treatment for Suicidal Ideation in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial

Special Episode: The Future of DSM

May 2026: Psychiatric Comorbidities in Substance Use Disorders: Sex-Based Differences in a National Real-World Clinical Sample

April 2026: Mobile Health for Alcohol Use Assessment: Longitudinal Effects of Breathalyzer Self-Monitoring in Everyday Contexts

March 2026: Primary Prevention of PTSD Symptoms in Combat-Deploying Soldiers Using Attention Bias Modification: A Randomized Controlled Trial